Gestational diabetes mellitus is associated with increased C-reactive protein concentrations in the third but not second trimester

European Journal of Clinical Investigation

Volumn 35, Issue 12, 2005, Pages 752-757

  Leipold, H ^a   Worda, Christof ^a   Gruber, C J ^a   Prikoszovich, T ^a   Wagner, O ^a   Kautzky Willer, A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Body mass index; C reactive protein; Gestational diabetes mellitus; Pregnancy

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GESTATIONAL AGE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LINEAR REGRESSION ANALYSIS; LONGITUDINAL STUDY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY;

EID: 28944442335     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2005.01574.x     Document Type: Article

References (26)

1. Sepe SJ, Connell FA, Geiss LS, Teutsch SM. Gestational diabetes. Incidence, maternal characteristics and perinatal outcome. Diabetes 1985;34 (Suppl. 2):13-6.
2. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. Endocr Rev 1998;19:477-90.
3. Catalano PM, Drago NM, Amini SB. Longitudinal changes in pancreatic beta-cell function and metabolic clearance rate of insulin in pregnant women with normal and abnormal glucose tolerance. Diabetes Care 1998;21:403-8.
4. Linne Y, Barkeling B, Rossner S. Natural course of gestational diabetes mellitus: long term follow up of women in the SPAWN study. BJOG 2002;109:1227-31.
5. Kjos SI, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes. Utility of the early postpartum glucose tolerance testing. Diabetes 1995;44:586-91.
6. Kushner I, Rzewnicki DL. The acute phase response: general aspects. Baillieres Clin Rheumatol 1994;8:513-30.
7. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin-resistance and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-8.
8. Ford ES. Body mass index, diabetes and C-reactive protein among US Adults. Diabetes Care 1999;22:1971-7.
9. Engström G, Stavenow L, Hedblad B, Lind P, Erikson KF, Janzon L et al. Inflammation-sensitive plasma proteins, diabetes and mortality and incidence of myocardial infarction and stroke. A Population-based study. Diabetes 2003;52:442-7.
10. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
11. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M et al. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 1997;17:1121-7.
12. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin-6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286:327-34.
13. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type-2 diabetes in women. Diabetes 2004;53:693-700.
14. Thorand B, Lowel H, Schneider A, Kolb H, Meisinger C, Frohlich M et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort study 1984-98. Arch Intern Med 2003;163:93-9.
15. Festa A, D'Agostino R, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome. Circulation 2000;102:42-7.
16. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H et al. Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000;23:1835-9.
17. Wolf M, Sauk J, Shah A, Vossen-Smirnakis K, Jimenez-Kimble R, Ecker JL et al. Inflammation and glucose intolerance: a prospective study of gestational diabetes mellitus. Diabetes Care 2004;27:21-7.
18. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 2003;88:3507-12.
19. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003;26:819-24.
20. Qiu C, Sorensen TK, Luthy DA, Williams MA. A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus. Paediatr Perinat Epidemiol 2004;18:377-84.
21. Deutsche Diabetes-Gesellschaft. Diagnostik und Therapie des Gestationsdiabetes. Richtlinien der Deutschen Diabetes-Gesellschaft (Diagnostic and therapy of GDM. Guidelines from the German Diabetes Association). Frauenarzt 1993;13-4.
22. Kautzky-Willer A, Prager R, Waldhäusl W, Pacini G, Thomaseth K, Wagner OF et al. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 1997;20:1717-23.
23. Buchanan TA. Pancreatic B-cell defects in gestational diabetes: implications for the pathogenesis and prevention of type-2 diabetes. J Clin Endocrinol Metab 2001;86:989-93.
24. Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type-2 diabetes in association with insulin resistance. Circulation 2000;101:1780-4.
25. Abderrahim-Ferkoune A, Bezy O, Chiellini C, Maffei M, Grimaldi P, Bonino F et al. Characterization of the long pentraxin PTX3 as a TNFalpha-induced secreted protein of adipose cells. J Lipid Res 2003;44:994-1000.
26. Watts DH, Krohn MA, Wener MH, Eschenbach DA. C-reactive protein in normal pregnancy. Obstet Gynecol 1991;77:176-80.